Related Experiment Video

Updated: Jun 26, 2026

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
09:37

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

The gene coding for PGC-1alpha modifies age at onset in Huntington's Disease

Patrick Weydt1, Selma M Soyal, Cinzia Gellera

  • 1Department of Neurology, University of Ulm (P,W,; G,B,L,), Ulm, Germany. patrick.weydt@uni-ulm.de.

Molecular Neurodegeneration
|January 10, 2009
PubMed

Insights

Huntington's disease (HD) onset is influenced by genetic factors beyond CAG repeats. Specific variants in the PGC-1alpha gene (PPARGC1A) can significantly delay disease progression in patients.

Area of Science:

  • Neurogenetics
  • Mitochondrial Biology
  • Neurodegenerative Diseases

Background:

  • Huntington's disease (HD) is an inherited neurodegenerative disorder characterized by motor, emotional, and cognitive decline.
  • Metabolic abnormalities, including wasting and altered energy expenditure, are recognized hallmarks of HD.
  • HD pathogenesis involves transcriptional dysregulation, mitochondrial dysfunction, and oxidative stress, with PGC-1alpha (encoded by PPARGC1A) identified as a potentially defective regulator.

Purpose of the Study:

  • To investigate the association between genetic variations in the PPARGC1A gene and the age of onset in Huntington's disease patients.
  • To determine if specific haplotypes of PPARGC1A influence disease progression, independent of CAG repeat length in the HTT gene.

Main Methods:

  • Analysis of 2-loci PPARGC1A block 2 haplotypes in 447 unrelated Huntington's disease patients.
  • Statistical consideration of CAG repeat lengths in both HTT alleles to isolate the effect of PPARGC1A haplotypes on age-at-onset.
  • Comparison of disease onset age between patients with different PPARGC1A haplotype combinations.

Main Results:

  • PPARGC1A block 2 haplotypes, but not block 1 haplotypes, were associated with the age of onset in HD patients.
  • Homozygosity for a specific 'protective' block 2 haplotype significantly delayed the onset of Huntington's disease.
  • This finding was statistically significant after accounting for the length of CAG repeats in the HTT gene.

Conclusions:

  • The PGC-1alpha system, through variations in the PPARGC1A gene, plays a clinically relevant role in modulating the age of onset for Huntington's disease in humans.
  • This study provides the first evidence of a genetic modifier effect of PGC-1alpha on HD progression in a human cohort.
  • Identifying genetic modifiers like PPARGC1A could offer new therapeutic targets for delaying Huntington's disease onset and progression.

More Related Videos

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System10:52

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System

Published on: December 10, 2021

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species07:08

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species

Published on: February 27, 2018

Related Concept Videos

Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Genetic Lingo01:11

Genetic Lingo

Overview
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...